Vital Start is a University of Pennsylvania’s Penn Center for Innovation (PCI) digital therapeutics company focused on smart, safe, value-based care across the continuum.

Our initial focus is on postpartum depression, a disorder affecting 950,000 women a year in the US and 11-20% of the global population.  The goal is to promote medical, social and behavioral support through effective psychosocial treatment, positive mental health/bonding between mothers and babies including those exposed to opioids for optimal long-term outcomes. Vital Start  was formerly SugarTool, incubated to manage complex neonatal ICU and Inpatient conditions that can have an adverse impact on the lives of babies and hence the future of population health.